29Nov NATCO Pharma informs about credit ratPursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..
21Nov USFDA concludes inspection at Natco PhThe U.S. Food and Drug Administration (USFDA) has concluded inspection a..
14Nov Demerger
Inter alia, approved:- 1. Declared second interim dividend of Rs.1.50..
31Oct NATCO Pharma informs about press release
NATCO Pharma has informed that it enclosed the Press Release under Regul..
31Oct Natco Pharma launches Everolimus tableNatco Pharma has launched Everolimus tablets 1mg, a generic version of Z..